• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗抵抗性抑郁症的影响:观点综述。

The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review.

机构信息

University Psychiatric Center KU Leuven and KU Leuven, Faculty of Medicine, Department of Neurosciences, Research Group Psychiatry.

University Psychiatric Center KU Leuven, Campus Kortenberg.

出版信息

Int J Neuropsychopharmacol. 2019 Feb 1;22(2):85-92. doi: 10.1093/ijnp/pyy052.

DOI:10.1093/ijnp/pyy052
PMID:29961822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6368367/
Abstract

Treatment-resistant depression refers to major depressive disorder, treatment of the disorder, and failure to obtain an "acceptable" outcome. Regarding the disorder, the heterogeneous concept of major depressive disorder and the multiple definitions of treatment-resistant depression, hesitating between a categorical and a more dimensional approach, as well as the divergence between diagnostic criteria and the items in the assessment scales are a source of confusion. Classifications do not take into account the dramatic influence of patient characteristics strongly impacting outcome, although these can be the cause of so-called pseudo-resistance. Outcome is the result of spontaneous evolution, nonspecific factors (including placebo), and active treatment factors. These should be differentiated to have a reliable estimation of the impact of different treatment modalities before we can asses treatment-resistant depression or before we can ascertain the (non)efficacy of treatments for treatment-resistant depression.The impact and burden of major depressive disorder and treatment-resistant depression are immense and go far beyond their economic cost. It is often forgotten that both are not only associated with increased suicidality but also with nonsuicidal mortality and that both can even result in requests for assisted dying. The caregiver burden and associated stigma are also too often overlooked despite that it has been suggested that they do influence (treatment) outcome.

摘要

治疗抵抗性抑郁症是指重性抑郁障碍、该障碍的治疗以及未能获得“可接受”的结果。关于该障碍,重性抑郁障碍的异质性概念和治疗抵抗性抑郁症的多种定义、在分类法和更具维度的方法之间犹豫不决、诊断标准和评估量表中的条目之间的分歧,这些都是造成混淆的原因。分类法没有考虑到强烈影响结局的患者特征的巨大影响,尽管这些可能是所谓的假性抵抗的原因。结局是自发演变、非特异性因素(包括安慰剂)和积极治疗因素的结果。应该对这些因素加以区分,以便在评估治疗抵抗性抑郁症之前可靠地估计不同治疗方式的影响,或者在确定治疗抵抗性抑郁症的治疗方法(无效)之前可靠地估计不同治疗方式的影响。重性抑郁障碍和治疗抵抗性抑郁症的影响和负担是巨大的,远远超出其经济成本。人们常常忘记,两者不仅与自杀率增加有关,而且与非自杀性死亡率有关,两者甚至可能导致请求协助自杀。尽管有人认为它会影响(治疗)结局,但护理者负担和相关耻辱感也经常被忽视。

相似文献

1
The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review.治疗抵抗性抑郁症的影响:观点综述。
Int J Neuropsychopharmacol. 2019 Feb 1;22(2):85-92. doi: 10.1093/ijnp/pyy052.
2
The mistreatment of major depressive disorder.重度抑郁症的虐待。
Can J Psychiatry. 2014 Mar;59(3):148-51. doi: 10.1177/070674371405900306.
3
A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.一项针对接受迷走神经刺激或常规治疗的治疗抵抗性抑郁症患者的 5 年观察性研究:反应、缓解和自杀率的比较。
Am J Psychiatry. 2017 Jul 1;174(7):640-648. doi: 10.1176/appi.ajp.2017.16010034. Epub 2017 Mar 31.
4
Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.治疗抵抗性抑郁症:定义、证据回顾和算法方法。
J Affect Disord. 2014 Mar;156:1-7. doi: 10.1016/j.jad.2013.10.043. Epub 2013 Nov 15.
5
A New Prediction Model for Evaluating Treatment-Resistant Depression.一种新的治疗抵抗性抑郁症评估预测模型。
J Clin Psychiatry. 2017 Feb;78(2):215-222. doi: 10.4088/JCP.15m10381.
6
Defining treatment-resistant depression: a comprehensive review of the literature.难治性抑郁症的定义:文献综述
Ann Clin Psychiatry. 2014 Aug;26(3):222-32.
7
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).重性抑郁障碍与自杀倾向的严重程度:欧洲难治性抑郁研究组(GSRD)的研究结果。
Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009.
8
Challenges of Treatment-resistant Depression.难治性抑郁症的挑战
Psychiatr Danub. 2018 Sep;30(3):273-284. doi: 10.24869/psyd.2018.273.
9
Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.重复经颅磁刺激与抗抑郁药治疗难治性抑郁症的成本效益分析
Value Health. 2015 Jul;18(5):597-604. doi: 10.1016/j.jval.2015.04.004.
10
Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.间歇性theta波爆发刺激(iTBS)和10赫兹高频重复经颅磁刺激(rTMS)治疗难治性单相抑郁症的疗效:一项随机对照试验的研究方案。
Trials. 2017 Jan 13;18(1):17. doi: 10.1186/s13063-016-1764-8.

引用本文的文献

1
Longitudinal associations between psychological factors, community integration, and suicide risks among patients with treatment-resistant depression in Vietnam.越南难治性抑郁症患者心理因素、社区融入与自杀风险之间的纵向关联。
Front Psychiatry. 2025 Jul 28;16:1597196. doi: 10.3389/fpsyt.2025.1597196. eCollection 2025.
2
Perspectives on Personalized Treatment in Difficult-to-Treat Depression: A Case Report.难治性抑郁症个性化治疗的观点:一例病例报告
Case Rep Psychiatry. 2025 May 6;2025:5538951. doi: 10.1155/crps/5538951. eCollection 2025.
3
Editorial: Treatment resistant depression (TRD): epidemiology, clinic, burden and treatment.社论:难治性抑郁症(TRD):流行病学、临床情况、负担及治疗
Front Psychiatry. 2025 Mar 18;16:1588902. doi: 10.3389/fpsyt.2025.1588902. eCollection 2025.
4
A systematic review of predictors and moderators of treatment response in psychological interventions for persisting forms of depression.对持续性抑郁症心理干预中治疗反应的预测因素和调节因素的系统评价。
Br J Clin Psychol. 2025 Sep;64(3):623-656. doi: 10.1111/bjc.12513. Epub 2024 Dec 31.
5
Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review.脑源性神经营养因子的变化及其在氯胺酮和艾司氯胺酮神经滋养性抗抑郁机制中的作用:综述
Int J Mol Sci. 2024 Dec 5;25(23):13098. doi: 10.3390/ijms252313098.
6
Anti-Amyloid Drugs for Alzheimer's Disease: Considering the Role of Depression.用于治疗阿尔茨海默病的抗淀粉样蛋白药物:考虑抑郁症的作用。
Neurodegener Dis. 2025;25(1):36-49. doi: 10.1159/000541783. Epub 2024 Dec 6.
7
Multifamily therapy in difficult-to-treat depression: an integrated and promising approach to rethinking clinical strategies.针对难治性抑郁症的多家庭治疗:一种重新思考临床策略的综合且有前景的方法。
Front Psychiatry. 2024 Oct 31;15:1484440. doi: 10.3389/fpsyt.2024.1484440. eCollection 2024.
8
Effects of repetitive transcranial magnetic stimulation therapy on weight and lipid metabolism in patients with treatment-resistant depression: A preliminary single-center retrospective cohort study.重复经颅磁刺激疗法对难治性抑郁症患者体重和脂质代谢的影响:一项初步的单中心回顾性队列研究。
Neuropsychopharmacol Rep. 2025 Mar;45(1):e12494. doi: 10.1002/npr2.12494. Epub 2024 Nov 9.
9
Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression.丘脑皮质功能连接以及低剂量氯胺酮输注对难治性抑郁症患者的快速抗抑郁和抗自杀作用。
Mol Psychiatry. 2025 Jan;30(1):61-68. doi: 10.1038/s41380-024-02640-3. Epub 2024 Jul 6.
10
The impact of ATP-binding cassette transporters in the diseased brain: Context matters.三磷酸腺苷结合盒转运蛋白在病变大脑中的作用:具体情况具体分析。
Cell Rep Med. 2024 Jun 18;5(6):101609. doi: 10.1016/j.xcrm.2024.101609.

本文引用的文献

1
Physician-Assisted Suicide and Psychiatric Illness.医生协助自杀与精神疾病
N Engl J Med. 2018 Mar 8;378(10):885-887. doi: 10.1056/NEJMp1714496.
2
Physicians' beliefs about placebo and nocebo effects in antidepressants - an online survey among German practitioners.医生对抗抑郁药中安慰剂和反安慰剂效应的看法——一项针对德国从业者的在线调查
PLoS One. 2017 May 31;12(5):e0178719. doi: 10.1371/journal.pone.0178719. eCollection 2017.
3
A Randomized, Controlled Trial of the Effectiveness of a Psychoeducational Intervention on Family Caregivers of Patients with Mental Disorders.一项关于心理教育干预对精神障碍患者家庭照顾者有效性的随机对照试验。
Community Ment Health J. 2018 Feb;54(2):211-217. doi: 10.1007/s10597-017-0126-7. Epub 2017 Apr 25.
4
Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough.迈向基于证据的难治性抑郁症操作性定义:何时才够。
JAMA Psychiatry. 2017 Jan 1;74(1):9-10. doi: 10.1001/jamapsychiatry.2016.2586.
5
Claims for sickness and disability benefits owing to mental disorders in the UK: trends from 1995 to 2014.英国因精神障碍申领疾病和残疾津贴的情况:1995年至2014年的趋势
BJPsych Open. 2016 Jan 13;2(1):18-24. doi: 10.1192/bjpo.bp.115.002246. eCollection 2016 Jan.
6
Euthanasia and Assisted Suicide of Patients With Psychiatric Disorders in the Netherlands 2011 to 2014.2011年至2014年荷兰精神疾病患者的安乐死与协助自杀情况
JAMA Psychiatry. 2016 Apr;73(4):362-8. doi: 10.1001/jamapsychiatry.2015.2887.
7
Physician-Assisted Dying: A Turning Point?医生协助下的死亡:一个转折点?
JAMA. 2016 Jan 19;315(3):249-50. doi: 10.1001/jama.2015.16586.
8
Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy for treatment-resistant depression: the Tavistock Adult Depression Study (TADS).长期精神分析心理治疗治疗抵抗性抑郁症的实用随机对照试验:塔维斯托克成人抑郁症研究(TADS)。
World Psychiatry. 2015 Oct;14(3):312-21. doi: 10.1002/wps.20267.
9
Euthanasia requests, procedures and outcomes for 100 Belgian patients suffering from psychiatric disorders: a retrospective, descriptive study.100例比利时精神疾病患者的安乐死请求、程序及结果:一项回顾性描述性研究
BMJ Open. 2015 Jul 27;5(7):e007454. doi: 10.1136/bmjopen-2014-007454.
10
Treatment-resistant major depressive disorder and assisted dying.难治性重度抑郁症与辅助死亡。
J Med Ethics. 2015 Aug;41(8):577-83. doi: 10.1136/medethics-2014-102458. Epub 2015 May 2.